Evidence map›Paper›PMID 37694289›Full record

ArticleInternational journal of cancer2024

Diagnostic accuracy of HPV16 early antigen serology for HPV-driven oropharyngeal cancer is independent of age and sex.

Johannes M A Kusters, Brenda Diergaarde, Andrew Ness, Maarten F Schim van der Loeff, Janneke C M Heijne, Lea Schroeder, Katrina Hueniken, James D McKay, Gary J Macfarlane, Pagona Lagiou and 21 more

Open access · hybridAbstract read
In one paragraph

Article in International journal of cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 20 institutions in 13 countries.

Johannes M A KustersCentre for Infectious Diseases Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.ORCID 0000-0002-2509-1661
Brenda DiergaardeSchool of Public Health, University of Pittsburgh and UPMC Hillman Cancer Centre, Pittsburgh, Pennsylvania, USA.
Andrew NessNIHR Bristol Biomedical Research Centre, Weston NHS Foundation Trust, University of Bristol, Bristol, UK.
Maarten F Schim van der LoeffInstitute for Infection and Immunity (AII), Amsterdam UMC, Amsterdam, The Netherlands.
Janneke C M HeijneCentre for Infectious Diseases Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Lea SchroederInfections and Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Katrina HuenikenPrincess Margaret Cancer Centre, Temerty School of Medicine, University of Toronto, Toronto, Ontario, Canada.
James D McKayGenomic Epidemiology Group, International Agency for Research on Cancer, Lyon, France.
Gary J MacfarlaneEpidemiology Group, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK.
Pagona LagiouSchool of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Areti LagiouSchool of Public Health, University of West Attica, Athens, Greece.
Jerry PoleselCentro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.ORCID 0000-0001-9381-1520
Antonio AgudoUnit of Nutrition and Cancer, Catalan Institute of Oncology - ICO, L'Hospitalet de Llobregat, Spain.
Laia AlemanyNutrition and Cancer Group, Epidemiology Public Health Cancer Prevention and Palliative Care Program, Bellvitge Biomedical Research Institute - IDIBELL, L'Hospitalet de Llobregat, Spain.
Wolfgang AhrensUniversity of Bremen, Bremen, Germany.
Claire M HealyTrinity College School of Dental Science, Dublin, Ireland.
David I ConwaySchool of Medicine, Dentistry, and Nursing, University of Glasgow, Dublin, UK.ORCID 0000-0001-7762-4063
Max RobinsonDepartment of Cellular Pathology, Royal Victoria Infirmary, Newcastle upon Tyne, UK.
Cristina CanovaUniversity of Padova, Padova, Italy.
Ivana HolcátováFirst Faculty of Medicine, Institute of Hygiene and Epidemiology, Charles University, Prague, Czech Republic.
Lorenzo RichiardiReference Center for Epidemiology and Cancer Prevention, Piemonte, Italy.
Ariana ZnaorGenomic Epidemiology Group, International Agency for Research on Cancer, Lyon, France.ORCID 0000-0002-5849-4782
Miranda PringBristol Dental School, University of Bristol, Bristol, UK.
Steve ThomasBristol Dental School, University of Bristol, Bristol, UK.
D Neil HayesDivision of Medical Oncology and Center for Cancer Research, University of Tennessee Health Science Center, Memphis, Tennessee, USA.ORCID 0000-0001-6203-7771
Geoffrey LiuPrincess Margaret Cancer Centre, Temerty School of Medicine, University of Toronto, Toronto, Ontario, Canada.
Rayjean J HungDalla Lana School of Public Health, University of Toronto, Toronto, Canada.ORCID 0000-0002-4486-7496
Paul BrennanGenomic Epidemiology Group, International Agency for Research on Cancer, Lyon, France.ORCID 0000-0002-0518-8714
Andrew F OlshanUniversity of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA.
Shama ViraniGenomic Epidemiology Group, International Agency for Research on Cancer, Lyon, France.
Tim WaterboerInfections and Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Centre international de recherche sur le cancer · FRGerman Cancer Research Center · DEUniversity Of Bristol Dental Hospital · GBUniversity of Toronto · CABellvitge University Hospital · ESCentro di Riferimento Oncologico · ITCharles University · CZGGD Amsterdam · NLInstituto de Salud Carlos III · ESMaastricht University · NLNational and Kapodistrian University of Athens · GRPiedmont Reference Center for Epidemiology and Cancer Prevention · ITRoyal Victoria Infirmary · GBTrinity College Dublin · IEUniversity of Aberdeen · GBUniversity of Bremen · DEUniversity of Glasgow · GBUniversity of North Carolina at Chapel Hill · USUniversity of Padua · ITUniversity of Tennessee Health Science Center · US

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JOHN C. BYRD · 1988 to 2026
$158.0M
WILD TYPE P53-BASED ADJUVANT IMMUNOTHERAPY FOR SCCHNP50CA097190 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Greg M. Delgoffe · 2004 to 2026
$49.6M
UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Stephanie Engel · 2001 to 2026
$36.3M
Gene Environment Interaction in Head and Neck CancerR01CA090731 · NCI · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI OLSHAN, ANDREW · 2001 to 2005
$4.6M
The role of germline and somatic DNA mutations in oral and oropharyngeal cancersR01DE025712 · NIDCR · INTERNATIONAL AGENCY FOR RES ON CANCER · PI BRENNAN, PAUL JOSEPH, DIERGAARDE, BRENDA B. · 2017 to 2021
$3.3M
Germline risk of oral and oropharyngeal cancers across diverse populationsR03DE030257 · NIDCR · INTERNATIONAL AGENCY FOR RES ON CANCER · PI VIRANI, SHAMA · 2021 to 2022
$222k
Medical Research Council MR/N005872/1NCI NIH HHS P30 CA047904NCI NIH HHS P50 CA097190NCI NIH HHS R01 CA090731NIDCR NIH HHS R01 DE025712NIDCR NIH HHS R03 DE030257NIEHS NIH HHS P30 ES010126NIH HHS P30CA047904NIH HHS P50CA097190World Health Organization 001
6 · The paper itself

Abstract

A growing proportion of head and neck cancer (HNC), especially oropharyngeal cancer (OPC), is caused by human papillomavirus (HPV). There are several markers for HPV-driven HNC, one being HPV early antigen serology. We aimed to investigate the diagnostic accuracy of HPV serology and its performance across patient characteristics. Data from the VOYAGER consortium was used, which comprises five studies on HNC from North America and Europe. Diagnostic accuracy, that is, sensitivity, specificity, Cohen's kappa and correctly classified proportions of HPV16 E6 serology, was assessed for OPC and other HNC using p16

Indexed as

Head and Neck NeoplasmsOropharyngeal NeoplasmsPapillomavirus InfectionsHuman papillomavirus 16Human Papillomavirus VirusesHumansdiagnostic accuracyhead and neck cancerhuman papillomavirusoropharyngeal cancerserology

Identifiers

PMID37694289
PMCPMC11552661
OpenAlexW4386593320

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.